83 related articles for article (PubMed ID: 10567682)
1. Different morphological changes of two colorectal adenocarcinoma cell lines after sodium butyrate treatment.
Stokrová J; Sovová V; Sloncová E; Korb J
Int J Mol Med; 1999 Dec; 4(6):669-74. PubMed ID: 10567682
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells.
Kobayashi H; Tan EM; Fleming SE
Int J Cancer; 2004 Mar; 109(2):207-13. PubMed ID: 14750171
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
4. Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate.
Stokrová J; Sloncová E; Sovová V; Kucerová D; Zíla V; Turecková J; Vojtechová M; Korb J; Tuhácková Z
Int J Oncol; 2006 Feb; 28(2):559-65. PubMed ID: 16391813
[TBL] [Abstract][Full Text] [Related]
5. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes.
Rada-Iglesias A; Enroth S; Ameur A; Koch CM; Clelland GK; Respuela-Alonso P; Wilcox S; Dovey OM; Ellis PD; Langford CF; Dunham I; Komorowski J; Wadelius C
Genome Res; 2007 Jun; 17(6):708-19. PubMed ID: 17567991
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
Gope R; Gope ML
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):589-97. PubMed ID: 8220069
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium butyrate, a new pharmacological agent, on cells in culture.
Kruh J
Mol Cell Biochem; 1982 Feb; 42(2):65-82. PubMed ID: 6174854
[TBL] [Abstract][Full Text] [Related]
10. In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells.
Olmo N; Turnay J; Pérez-Ramos P; Lecona E; Barrasa JI; López de Silanes I; Lizarbe MA
Toxicol In Vitro; 2007 Mar; 21(2):262-70. PubMed ID: 17084582
[TBL] [Abstract][Full Text] [Related]
11. Effects of arginine butyrate and tributyrylxylitol on cultured human sarcoma cells.
Vincent-Fiquet O; Rogez JC; Boitte F; Brazier M; Desmet G
Anticancer Res; 1994; 14(5A):1823-8. PubMed ID: 7531414
[TBL] [Abstract][Full Text] [Related]
12. H3K9 acetylation and radial chromatin positioning.
Strasák L; Bártová E; Harnicarová A; Galiová G; Krejcí J; Kozubek S
J Cell Physiol; 2009 Jul; 220(1):91-101. PubMed ID: 19248079
[TBL] [Abstract][Full Text] [Related]
13. Response of HT115, a highly invasive human colorectal adenocarcinoma cell line, to sodium butyrate treatment and glucose deprivation.
Stokrová J; Sovová V; Sloncová E; Kucerová D; Tuhácková Z; Korb J
Int J Oncol; 2005 Mar; 26(3):793-9. PubMed ID: 15703838
[TBL] [Abstract][Full Text] [Related]
14. Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes.
Sun X; Zhu MJ
Mol Nutr Food Res; 2018 May; 62(10):e1700932. PubMed ID: 29577594
[TBL] [Abstract][Full Text] [Related]
15. Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Yabushita H; Sartorelli AC
Oncol Res; 1993; 5(4-5):173-82. PubMed ID: 8305743
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
Karasawa Y; Okisaka S
Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Hay FG; Duncan LW; Langdon SP; Leonard RC
Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells.
McCue PA; Gubler ML; Sherman MI; Cohen BN
J Cell Biol; 1984 Feb; 98(2):602-8. PubMed ID: 6141173
[TBL] [Abstract][Full Text] [Related]
19. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines.
Chung YS; Song IS; Erickson RH; Sleisenger MH; Kim YS
Cancer Res; 1985 Jul; 45(7):2976-82. PubMed ID: 4005836
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors reverse butyrate stimulation of human Caco-2 intestinal epithelial cell alkaline phosphatase but not butyrate promotion of dipeptidyl dipeptidase.
Basson MD; Hong F
Cell Biol Int; 1998; 22(5):339-44. PubMed ID: 10198153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
